A Paris medtech specializing in AI-driven biomarkers.nnKey FeaturesnUses smartphone sensor data (gait, finger tapping, cognitive tests) to monitor the progression of Multiple Sclerosis (MS) in real-time.nnUse CasenPatients use the app at home to provide ‘real-world data’ to their neurologists, allowing for treatment adjustments between hospital visits.nnWhy Choose Ad Scientiam?nIt turns a standard smartphone into a clinical-grade monitoring tool, providing a more accurate picture of a patient’s daily health.